Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT)
使用 HSIL 筛查和治疗预防肛门癌的综合模型 (IMPACT)
基本信息
- 批准号:10540829
- 负责人:
- 金额:$ 77.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-15 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAdoptionAnusCancer ControlCancer Prevention InterventionCaringClientClient satisfactionClinicCommunitiesConsolidated Framework for Implementation ResearchDataDevelopmentEnrollmentEnsureEnvironmentEvidence based interventionEvidence based treatmentFeasibility StudiesGeneral PopulationGoalsGroup InterviewsHIVHIV riskHPV-High RiskHybridsInfrastructureInternationalInterruptionInterventionInterviewKnowledgeLanguageLearningMaintenanceMalignant neoplasm of anusMethodsModelingNeoplasmsNigeriaOutcomeParticipantPatientsPersonsPhysiciansPopulationPrevalencePreventionProspective StudiesRandomized Controlled TrialsReach Effectiveness Adoption Implementation and MaintenanceRecommendationRiskRisk FactorsScreening ResultScreening for cancerSeriesSiteSocietiesSquamous intraepithelial lesionStructureTestingTimeTrainingUnited StatesUrsidae FamilyVirusWorkanticancer researchbasecancer preventioncancer riskclinical research sitecohortcost effectivedesigneducational atmosphereevidence baseevidence based guidelinesexperiencefollow-upimplementation barriersimplementation interventionimplementation scienceimplementation strategyimprovedinsightlow and middle-income countriesmen who have sex with menmultidisciplinarypreventprimary outcomeprophylacticscale upscreeningscreening guidelinessecondary outcometooluptake
项目摘要
Project Abstract
Anal cancer risk is 80-fold higher among men who have sex with men (MSM) living with HIV compared to the
general population, making MSM a critical population for implementing evidence-based anal cancer prevention
interventions. A randomized controlled trial at 21 clinical sites in the United States of people living with HIV,
recently established treatment of high-grade squamous intraepithelial lesions (HSIL) as an evidence-based
intervention (EBI) for anal cancer prevention. Given its established efficacy, HSIL screening and treatment
should be implemented as prophylactic care to prevent anal cancer in low- and middle-income country (LMIC)
settings where HIV is highly prevalent. To accelerate adoption of HSIL screening and treatment in LMIC settings,
we will leverage an existing HIV infrastructure, the TRUST clinic, an MSM-friendly facility in Nigeria that has
been providing HIV care to a cohort of MSM since 2012. We conducted a proof-of-concept anal cancer screening
and treatment study at the TRUST clinic and found high uptake in the MSM community; representativeness, as
those screened had similar prevalence of HIV and high-risk human papillomavirus as our overall cohort; and
overall patient satisfaction. Despite high screening volumes, we under-detected and under-treated HSIL.
Knowledge gaps in HSIL screening and treatment among both the care team and the participants were identified
as major barriers that impeded implementation of the EBI with fidelity. The objective of the proposed Integrated
Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT) study is to address these
barriers while capitalizing on facilitators within the existing TRUST clinic infrastructure to create an enhanced
training on Screening and Treatment of HSIL (e-STH) intervention. To achieve this goal, in AIM 1, we will use
the Consolidated Framework for Implementation Research (CFIR) and mixed methods to identify barriers and
facilitators to usual training on the EBI at the TRUST clinic. In AIM 2, we will engage an implementation team to
co-design the e-STH intervention by matching the barriers identified with CFIR with specific strategies in the
Expert Recommendations for Implementing Change (ERIC) framework. We will then take an iterative
improvement approach to test and refine the implementation of the e-STH intervention based on specific
outcomes. In AIM 3, we will conduct a prospective study to evaluate the reach, efficacy, and implementation and
explore the sustainability of e-STH compared to usual training using the RE-AIM framework. The proposed
IMPACT study will provide insight into implementation of an HSIL screening and treatment EBI adapted for
existing community-based HIV clinics in Nigeria and generate essential evidence for scalability across LMICs.
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sylvia Adebajo其他文献
Sylvia Adebajo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sylvia Adebajo', 18)}}的其他基金
Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center
使用证据对性和性别少数青少年进行弹性艾滋病毒实施科学 (RISE) 临床研究中心
- 批准号:
10749084 - 财政年份:2023
- 资助金额:
$ 77.32万 - 项目类别:
Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT)
使用 HSIL 筛查和治疗预防肛门癌的综合模型 (IMPACT)
- 批准号:
10705313 - 财政年份:2022
- 资助金额:
$ 77.32万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 77.32万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 77.32万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 77.32万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 77.32万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 77.32万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 77.32万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 77.32万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 77.32万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 77.32万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 77.32万 - 项目类别:
Fellowship Programs














{{item.name}}会员




